Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition

Background Long non-coding RNAs (lncRNAs) play a fundamental role in colorectal cancer (CRC) development, however, lncRNA expression profiles in CRC and its precancerous stages remain to be explored. We aimed to study whole genomic lncRNA expression patterns in colorectal adenoma–carcinoma transitio...

Full description

Saved in:
Bibliographic Details
Published inBMC cancer Vol. 19; no. 1; pp. 1059 - 16
Main Authors Kalmár, Alexandra, Nagy, Zsófia Brigitta, Galamb, Orsolya, Csabai, István, Bodor, András, Wichmann, Barnabás, Valcz, Gábor, Barták, Barbara Kinga, Tulassay, Zsolt, Igaz, Peter, Molnár, Béla
Format Journal Article
LanguageEnglish
Published London BioMed Central 06.11.2019
BioMed Central Ltd
BMC
Subjects
Adenoma
Adenoma - genetics
Adenoma - pathology
Adult
Advertising executives
Aged
Algorithms
Analysis
Biomedical and Life Sciences
Biomedicine
Biotechnology industries
Cancer genetics
Cancer Research
Carcinogenesis
Carcinoma
Carcinoma - genetics
Carcinoma - pathology
Colorectal adenoma
Colorectal cancer
Colorectal Neoplasms - genetics
Colorectal Neoplasms - pathology
Development and progression
Gastrointestinal diseases
Gene Expression Profiling - methods
Gene Expression Regulation, Neoplastic
Gene Ontology
Gene Regulatory Networks
Genetics
Genomes
Genomics
genomics and epigenetics
Health Promotion and Disease Prevention
Human transcriptome Array 2.0
Humans
Immunohistochemistry
lncRNA
Long non-coding RNA
Medicine/Public Health
Messenger RNA
Microarray
MicroRNA
Middle Aged
Models, Genetic
Oncology
Research Article
RNA
RNA, Long Noncoding - genetics
Surgical Oncology
Tumors
Young Adult
United States
Immunohistochemistry
Colorectal adenoma
lncRNA
Colorectal cancer
qRT-PCR
UCA1
Human transcriptome Array 2.0
Microarray
hybridization
Long non-coding RNA
In situ hybridization
Online AccessGet full text
ISSN1471-2407
1471-2407
DOI10.1186/s12885-019-6180-5

Cover

Abstract Background Long non-coding RNAs (lncRNAs) play a fundamental role in colorectal cancer (CRC) development, however, lncRNA expression profiles in CRC and its precancerous stages remain to be explored. We aimed to study whole genomic lncRNA expression patterns in colorectal adenoma–carcinoma transition and to analyze the underlying functional interactions of aberrantly expressed lncRNAs. Methods LncRNA expression levels of colonic biopsy samples (20 CRCs, 20 adenomas (Ad), 20 healthy controls (N)) were analyzed with Human Transcriptome Array (HTA) 2.0. Expression of a subset of candidates was verified by qRT-PCR and in situ hybridization (ISH) analyses. Furthermore, in silico validation was performed on an independent HTA 2.0, on HGU133Plus 2.0 array data and on the TCGA COAD dataset. MiRNA targets of lncRNAs were predicted with miRCODE and lncBase v2 algorithms and miRNA expression was analyzed on miRNA3.0 Array data. MiRNA-mRNA target prediction was performed using miRWALK and c-Met protein levels were analyzed by immunohistochemistry. Comprehensive lncRNA-mRNA-miRNA co-expression pattern analysis was also performed. Results Based on our HTA results, a subset of literature-based CRC-associated lncRNAs showed remarkable expression changes already in precancerous colonic lesions. In both Ad vs. normal and CRC vs. normal comparisons 16 lncRNAs, including downregulated LINC02023, MEG8, AC092834.1, and upregulated CCAT1, CASC19 were identified showing differential expression during early carcinogenesis that persisted until CRC formation (FDR-adjusted p  < 0.05). The intersection of CRC vs. N and CRC vs. Ad comparisons defines lncRNAs characteristic of malignancy in colonic tumors, where significant downregulation of LINC01752 and overexpression of UCA1 and PCAT1 were found. Two candidates with the greatest increase in expression in the adenoma-carcinoma transition were further confirmed by qRT-PCR (UCA1, CCAT1) and by ISH (UCA1). In line with aberrant expression of certain lncRNAs in tumors, the expression of miRNA and mRNA targets showed systematic alterations. For example, UCA1 upregulation in CRC samples occurred in parallel with hsa-miR-1 downregulation, accompanied by c-Met target mRNA overexpression ( p  < 0.05). Conclusion The defined lncRNA sets may have a regulatory role in the colorectal adenoma-carcinoma transition. A subset of CRC-associated lncRNAs showed significantly differential expression in precancerous samples, raising the possibility of developing adenoma-specific markers for early detection of colonic lesions.
AbstractList Abstract Background Long non-coding RNAs (lncRNAs) play a fundamental role in colorectal cancer (CRC) development, however, lncRNA expression profiles in CRC and its precancerous stages remain to be explored. We aimed to study whole genomic lncRNA expression patterns in colorectal adenoma–carcinoma transition and to analyze the underlying functional interactions of aberrantly expressed lncRNAs. Methods LncRNA expression levels of colonic biopsy samples (20 CRCs, 20 adenomas (Ad), 20 healthy controls (N)) were analyzed with Human Transcriptome Array (HTA) 2.0. Expression of a subset of candidates was verified by qRT-PCR and in situ hybridization (ISH) analyses. Furthermore, in silico validation was performed on an independent HTA 2.0, on HGU133Plus 2.0 array data and on the TCGA COAD dataset. MiRNA targets of lncRNAs were predicted with miRCODE and lncBase v2 algorithms and miRNA expression was analyzed on miRNA3.0 Array data. MiRNA-mRNA target prediction was performed using miRWALK and c-Met protein levels were analyzed by immunohistochemistry. Comprehensive lncRNA-mRNA-miRNA co-expression pattern analysis was also performed. Results Based on our HTA results, a subset of literature-based CRC-associated lncRNAs showed remarkable expression changes already in precancerous colonic lesions. In both Ad vs. normal and CRC vs. normal comparisons 16 lncRNAs, including downregulated LINC02023, MEG8, AC092834.1, and upregulated CCAT1, CASC19 were identified showing differential expression during early carcinogenesis that persisted until CRC formation (FDR-adjusted p < 0.05). The intersection of CRC vs. N and CRC vs. Ad comparisons defines lncRNAs characteristic of malignancy in colonic tumors, where significant downregulation of LINC01752 and overexpression of UCA1 and PCAT1 were found. Two candidates with the greatest increase in expression in the adenoma-carcinoma transition were further confirmed by qRT-PCR (UCA1, CCAT1) and by ISH (UCA1). In line with aberrant expression of certain lncRNAs in tumors, the expression of miRNA and mRNA targets showed systematic alterations. For example, UCA1 upregulation in CRC samples occurred in parallel with hsa-miR-1 downregulation, accompanied by c-Met target mRNA overexpression (p < 0.05). Conclusion The defined lncRNA sets may have a regulatory role in the colorectal adenoma-carcinoma transition. A subset of CRC-associated lncRNAs showed significantly differential expression in precancerous samples, raising the possibility of developing adenoma-specific markers for early detection of colonic lesions.
Long non-coding RNAs (lncRNAs) play a fundamental role in colorectal cancer (CRC) development, however, lncRNA expression profiles in CRC and its precancerous stages remain to be explored. We aimed to study whole genomic lncRNA expression patterns in colorectal adenoma-carcinoma transition and to analyze the underlying functional interactions of aberrantly expressed lncRNAs. LncRNA expression levels of colonic biopsy samples (20 CRCs, 20 adenomas (Ad), 20 healthy controls (N)) were analyzed with Human Transcriptome Array (HTA) 2.0. Expression of a subset of candidates was verified by qRT-PCR and in situ hybridization (ISH) analyses. Furthermore, in silico validation was performed on an independent HTA 2.0, on HGU133Plus 2.0 array data and on the TCGA COAD dataset. MiRNA targets of lncRNAs were predicted with miRCODE and lncBase v2 algorithms and miRNA expression was analyzed on miRNA3.0 Array data. MiRNA-mRNA target prediction was performed using miRWALK and c-Met protein levels were analyzed by immunohistochemistry. Comprehensive lncRNA-mRNA-miRNA co-expression pattern analysis was also performed. Based on our HTA results, a subset of literature-based CRC-associated lncRNAs showed remarkable expression changes already in precancerous colonic lesions. In both Ad vs. normal and CRC vs. normal comparisons 16 lncRNAs, including downregulated LINC02023, MEG8, AC092834.1, and upregulated CCAT1, CASC19 were identified showing differential expression during early carcinogenesis that persisted until CRC formation (FDR-adjusted p < 0.05). The intersection of CRC vs. N and CRC vs. Ad comparisons defines lncRNAs characteristic of malignancy in colonic tumors, where significant downregulation of LINC01752 and overexpression of UCA1 and PCAT1 were found. Two candidates with the greatest increase in expression in the adenoma-carcinoma transition were further confirmed by qRT-PCR (UCA1, CCAT1) and by ISH (UCA1). In line with aberrant expression of certain lncRNAs in tumors, the expression of miRNA and mRNA targets showed systematic alterations. For example, UCA1 upregulation in CRC samples occurred in parallel with hsa-miR-1 downregulation, accompanied by c-Met target mRNA overexpression (p < 0.05). The defined lncRNA sets may have a regulatory role in the colorectal adenoma-carcinoma transition. A subset of CRC-associated lncRNAs showed significantly differential expression in precancerous samples, raising the possibility of developing adenoma-specific markers for early detection of colonic lesions.
Background Long non-coding RNAs (lncRNAs) play a fundamental role in colorectal cancer (CRC) development, however, lncRNA expression profiles in CRC and its precancerous stages remain to be explored. We aimed to study whole genomic lncRNA expression patterns in colorectal adenoma-carcinoma transition and to analyze the underlying functional interactions of aberrantly expressed lncRNAs. Methods LncRNA expression levels of colonic biopsy samples (20 CRCs, 20 adenomas (Ad), 20 healthy controls (N)) were analyzed with Human Transcriptome Array (HTA) 2.0. Expression of a subset of candidates was verified by qRT-PCR and in situ hybridization (ISH) analyses. Furthermore, in silico validation was performed on an independent HTA 2.0, on HGU133Plus 2.0 array data and on the TCGA COAD dataset. MiRNA targets of lncRNAs were predicted with miRCODE and lncBase v2 algorithms and miRNA expression was analyzed on miRNA3.0 Array data. MiRNA-mRNA target prediction was performed using miRWALK and c-Met protein levels were analyzed by immunohistochemistry. Comprehensive lncRNA-mRNA-miRNA co-expression pattern analysis was also performed. Results Based on our HTA results, a subset of literature-based CRC-associated lncRNAs showed remarkable expression changes already in precancerous colonic lesions. In both Ad vs. normal and CRC vs. normal comparisons 16 lncRNAs, including downregulated LINC02023, MEG8, AC092834.1, and upregulated CCAT1, CASC19 were identified showing differential expression during early carcinogenesis that persisted until CRC formation (FDR-adjusted p < 0.05). The intersection of CRC vs. N and CRC vs. Ad comparisons defines lncRNAs characteristic of malignancy in colonic tumors, where significant downregulation of LINC01752 and overexpression of UCA1 and PCAT1 were found. Two candidates with the greatest increase in expression in the adenoma-carcinoma transition were further confirmed by qRT-PCR (UCA1, CCAT1) and by ISH (UCA1). In line with aberrant expression of certain lncRNAs in tumors, the expression of miRNA and mRNA targets showed systematic alterations. For example, UCA1 upregulation in CRC samples occurred in parallel with hsa-miR-1 downregulation, accompanied by c-Met target mRNA overexpression (p < 0.05). Conclusion The defined lncRNA sets may have a regulatory role in the colorectal adenoma-carcinoma transition. A subset of CRC-associated lncRNAs showed significantly differential expression in precancerous samples, raising the possibility of developing adenoma-specific markers for early detection of colonic lesions. Keywords: Long non-coding RNA, lncRNA, Colorectal cancer, Colorectal adenoma, Human transcriptome Array 2.0, Microarray, qRT-PCR, UCA1, Immunohistochemistry, In situ hybridization
Long non-coding RNAs (lncRNAs) play a fundamental role in colorectal cancer (CRC) development, however, lncRNA expression profiles in CRC and its precancerous stages remain to be explored. We aimed to study whole genomic lncRNA expression patterns in colorectal adenoma-carcinoma transition and to analyze the underlying functional interactions of aberrantly expressed lncRNAs.BACKGROUNDLong non-coding RNAs (lncRNAs) play a fundamental role in colorectal cancer (CRC) development, however, lncRNA expression profiles in CRC and its precancerous stages remain to be explored. We aimed to study whole genomic lncRNA expression patterns in colorectal adenoma-carcinoma transition and to analyze the underlying functional interactions of aberrantly expressed lncRNAs.LncRNA expression levels of colonic biopsy samples (20 CRCs, 20 adenomas (Ad), 20 healthy controls (N)) were analyzed with Human Transcriptome Array (HTA) 2.0. Expression of a subset of candidates was verified by qRT-PCR and in situ hybridization (ISH) analyses. Furthermore, in silico validation was performed on an independent HTA 2.0, on HGU133Plus 2.0 array data and on the TCGA COAD dataset. MiRNA targets of lncRNAs were predicted with miRCODE and lncBase v2 algorithms and miRNA expression was analyzed on miRNA3.0 Array data. MiRNA-mRNA target prediction was performed using miRWALK and c-Met protein levels were analyzed by immunohistochemistry. Comprehensive lncRNA-mRNA-miRNA co-expression pattern analysis was also performed.METHODSLncRNA expression levels of colonic biopsy samples (20 CRCs, 20 adenomas (Ad), 20 healthy controls (N)) were analyzed with Human Transcriptome Array (HTA) 2.0. Expression of a subset of candidates was verified by qRT-PCR and in situ hybridization (ISH) analyses. Furthermore, in silico validation was performed on an independent HTA 2.0, on HGU133Plus 2.0 array data and on the TCGA COAD dataset. MiRNA targets of lncRNAs were predicted with miRCODE and lncBase v2 algorithms and miRNA expression was analyzed on miRNA3.0 Array data. MiRNA-mRNA target prediction was performed using miRWALK and c-Met protein levels were analyzed by immunohistochemistry. Comprehensive lncRNA-mRNA-miRNA co-expression pattern analysis was also performed.Based on our HTA results, a subset of literature-based CRC-associated lncRNAs showed remarkable expression changes already in precancerous colonic lesions. In both Ad vs. normal and CRC vs. normal comparisons 16 lncRNAs, including downregulated LINC02023, MEG8, AC092834.1, and upregulated CCAT1, CASC19 were identified showing differential expression during early carcinogenesis that persisted until CRC formation (FDR-adjusted p < 0.05). The intersection of CRC vs. N and CRC vs. Ad comparisons defines lncRNAs characteristic of malignancy in colonic tumors, where significant downregulation of LINC01752 and overexpression of UCA1 and PCAT1 were found. Two candidates with the greatest increase in expression in the adenoma-carcinoma transition were further confirmed by qRT-PCR (UCA1, CCAT1) and by ISH (UCA1). In line with aberrant expression of certain lncRNAs in tumors, the expression of miRNA and mRNA targets showed systematic alterations. For example, UCA1 upregulation in CRC samples occurred in parallel with hsa-miR-1 downregulation, accompanied by c-Met target mRNA overexpression (p < 0.05).RESULTSBased on our HTA results, a subset of literature-based CRC-associated lncRNAs showed remarkable expression changes already in precancerous colonic lesions. In both Ad vs. normal and CRC vs. normal comparisons 16 lncRNAs, including downregulated LINC02023, MEG8, AC092834.1, and upregulated CCAT1, CASC19 were identified showing differential expression during early carcinogenesis that persisted until CRC formation (FDR-adjusted p < 0.05). The intersection of CRC vs. N and CRC vs. Ad comparisons defines lncRNAs characteristic of malignancy in colonic tumors, where significant downregulation of LINC01752 and overexpression of UCA1 and PCAT1 were found. Two candidates with the greatest increase in expression in the adenoma-carcinoma transition were further confirmed by qRT-PCR (UCA1, CCAT1) and by ISH (UCA1). In line with aberrant expression of certain lncRNAs in tumors, the expression of miRNA and mRNA targets showed systematic alterations. For example, UCA1 upregulation in CRC samples occurred in parallel with hsa-miR-1 downregulation, accompanied by c-Met target mRNA overexpression (p < 0.05).The defined lncRNA sets may have a regulatory role in the colorectal adenoma-carcinoma transition. A subset of CRC-associated lncRNAs showed significantly differential expression in precancerous samples, raising the possibility of developing adenoma-specific markers for early detection of colonic lesions.CONCLUSIONThe defined lncRNA sets may have a regulatory role in the colorectal adenoma-carcinoma transition. A subset of CRC-associated lncRNAs showed significantly differential expression in precancerous samples, raising the possibility of developing adenoma-specific markers for early detection of colonic lesions.
Background Long non-coding RNAs (lncRNAs) play a fundamental role in colorectal cancer (CRC) development, however, lncRNA expression profiles in CRC and its precancerous stages remain to be explored. We aimed to study whole genomic lncRNA expression patterns in colorectal adenoma–carcinoma transition and to analyze the underlying functional interactions of aberrantly expressed lncRNAs. Methods LncRNA expression levels of colonic biopsy samples (20 CRCs, 20 adenomas (Ad), 20 healthy controls (N)) were analyzed with Human Transcriptome Array (HTA) 2.0. Expression of a subset of candidates was verified by qRT-PCR and in situ hybridization (ISH) analyses. Furthermore, in silico validation was performed on an independent HTA 2.0, on HGU133Plus 2.0 array data and on the TCGA COAD dataset. MiRNA targets of lncRNAs were predicted with miRCODE and lncBase v2 algorithms and miRNA expression was analyzed on miRNA3.0 Array data. MiRNA-mRNA target prediction was performed using miRWALK and c-Met protein levels were analyzed by immunohistochemistry. Comprehensive lncRNA-mRNA-miRNA co-expression pattern analysis was also performed. Results Based on our HTA results, a subset of literature-based CRC-associated lncRNAs showed remarkable expression changes already in precancerous colonic lesions. In both Ad vs. normal and CRC vs. normal comparisons 16 lncRNAs, including downregulated LINC02023, MEG8, AC092834.1, and upregulated CCAT1, CASC19 were identified showing differential expression during early carcinogenesis that persisted until CRC formation (FDR-adjusted p  < 0.05). The intersection of CRC vs. N and CRC vs. Ad comparisons defines lncRNAs characteristic of malignancy in colonic tumors, where significant downregulation of LINC01752 and overexpression of UCA1 and PCAT1 were found. Two candidates with the greatest increase in expression in the adenoma-carcinoma transition were further confirmed by qRT-PCR (UCA1, CCAT1) and by ISH (UCA1). In line with aberrant expression of certain lncRNAs in tumors, the expression of miRNA and mRNA targets showed systematic alterations. For example, UCA1 upregulation in CRC samples occurred in parallel with hsa-miR-1 downregulation, accompanied by c-Met target mRNA overexpression ( p  < 0.05). Conclusion The defined lncRNA sets may have a regulatory role in the colorectal adenoma-carcinoma transition. A subset of CRC-associated lncRNAs showed significantly differential expression in precancerous samples, raising the possibility of developing adenoma-specific markers for early detection of colonic lesions.
Long non-coding RNAs (lncRNAs) play a fundamental role in colorectal cancer (CRC) development, however, lncRNA expression profiles in CRC and its precancerous stages remain to be explored. We aimed to study whole genomic lncRNA expression patterns in colorectal adenoma-carcinoma transition and to analyze the underlying functional interactions of aberrantly expressed lncRNAs. LncRNA expression levels of colonic biopsy samples (20 CRCs, 20 adenomas (Ad), 20 healthy controls (N)) were analyzed with Human Transcriptome Array (HTA) 2.0. Expression of a subset of candidates was verified by qRT-PCR and in situ hybridization (ISH) analyses. Furthermore, in silico validation was performed on an independent HTA 2.0, on HGU133Plus 2.0 array data and on the TCGA COAD dataset. MiRNA targets of lncRNAs were predicted with miRCODE and lncBase v2 algorithms and miRNA expression was analyzed on miRNA3.0 Array data. MiRNA-mRNA target prediction was performed using miRWALK and c-Met protein levels were analyzed by immunohistochemistry. Comprehensive lncRNA-mRNA-miRNA co-expression pattern analysis was also performed. Based on our HTA results, a subset of literature-based CRC-associated lncRNAs showed remarkable expression changes already in precancerous colonic lesions. In both Ad vs. normal and CRC vs. normal comparisons 16 lncRNAs, including downregulated LINC02023, MEG8, AC092834.1, and upregulated CCAT1, CASC19 were identified showing differential expression during early carcinogenesis that persisted until CRC formation (FDR-adjusted p < 0.05). The intersection of CRC vs. N and CRC vs. Ad comparisons defines lncRNAs characteristic of malignancy in colonic tumors, where significant downregulation of LINC01752 and overexpression of UCA1 and PCAT1 were found. Two candidates with the greatest increase in expression in the adenoma-carcinoma transition were further confirmed by qRT-PCR (UCA1, CCAT1) and by ISH (UCA1). In line with aberrant expression of certain lncRNAs in tumors, the expression of miRNA and mRNA targets showed systematic alterations. For example, UCA1 upregulation in CRC samples occurred in parallel with hsa-miR-1 downregulation, accompanied by c-Met target mRNA overexpression (p < 0.05). The defined lncRNA sets may have a regulatory role in the colorectal adenoma-carcinoma transition. A subset of CRC-associated lncRNAs showed significantly differential expression in precancerous samples, raising the possibility of developing adenoma-specific markers for early detection of colonic lesions.
ArticleNumber 1059
Audience Academic
Author Galamb, Orsolya
Molnár, Béla
Kalmár, Alexandra
Bodor, András
Barták, Barbara Kinga
Igaz, Peter
Csabai, István
Wichmann, Barnabás
Valcz, Gábor
Tulassay, Zsolt
Nagy, Zsófia Brigitta
Author_xml – sequence: 1
  givenname: Alexandra
  orcidid: 0000-0002-3824-1534
  surname: Kalmár
  fullname: Kalmár, Alexandra
  email: alexandra.kalmar@gmail.com
  organization: 2nd Department of Internal Medicine, Semmelweis University, Molecular Medicine Research Unit, Hungarian Academy of Sciences
– sequence: 2
  givenname: Zsófia Brigitta
  surname: Nagy
  fullname: Nagy, Zsófia Brigitta
  organization: 2nd Department of Internal Medicine, Semmelweis University
– sequence: 3
  givenname: Orsolya
  surname: Galamb
  fullname: Galamb, Orsolya
  organization: 2nd Department of Internal Medicine, Semmelweis University, Molecular Medicine Research Unit, Hungarian Academy of Sciences
– sequence: 4
  givenname: István
  surname: Csabai
  fullname: Csabai, István
  organization: Department of Physics of Complex Systems, Eötvös Loránd University
– sequence: 5
  givenname: András
  surname: Bodor
  fullname: Bodor, András
  organization: Department of Physics of Complex Systems, Eötvös Loránd University
– sequence: 6
  givenname: Barnabás
  surname: Wichmann
  fullname: Wichmann, Barnabás
  organization: 2nd Department of Internal Medicine, Semmelweis University, Molecular Medicine Research Unit, Hungarian Academy of Sciences
– sequence: 7
  givenname: Gábor
  surname: Valcz
  fullname: Valcz, Gábor
  organization: 2nd Department of Internal Medicine, Semmelweis University, Molecular Medicine Research Unit, Hungarian Academy of Sciences
– sequence: 8
  givenname: Barbara Kinga
  surname: Barták
  fullname: Barták, Barbara Kinga
  organization: 2nd Department of Internal Medicine, Semmelweis University
– sequence: 9
  givenname: Zsolt
  surname: Tulassay
  fullname: Tulassay, Zsolt
  organization: 2nd Department of Internal Medicine, Semmelweis University, Molecular Medicine Research Unit, Hungarian Academy of Sciences
– sequence: 10
  givenname: Peter
  surname: Igaz
  fullname: Igaz, Peter
  organization: 2nd Department of Internal Medicine, Semmelweis University, Molecular Medicine Research Unit, Hungarian Academy of Sciences
– sequence: 11
  givenname: Béla
  surname: Molnár
  fullname: Molnár, Béla
  organization: 2nd Department of Internal Medicine, Semmelweis University, Molecular Medicine Research Unit, Hungarian Academy of Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31694571$$D View this record in MEDLINE/PubMed
BookMark eNqNkl-L1DAUxYusuH_0A_giBUH0oWvSJk36sjAsug4sCqs-hzS97WRIkzFp3d1vb2rHZSqySB8akt85yb3nniZH1llIkpcYnWPMy_cB55zTDOEqKzFHGX2SnGDCcJYTxI4O1sfJaQhbhDDjiD9LjgtcVoQyfJL0V2BdD9mtbiCFu52HELSz6c67Vhttu1TbVDnjPKhBmlRJq8CnrVNjmE4jaqy6-bwKEzhsIJXN5CgzJb3S0yodvLRBD9H2efK0lSbAi_3_LPn-8cO3y0_Z9Zer9eXqOlMlQUMmGWNVBUo1JcnjOxtStRUnFLUEFKI1B2hISQilvMYtrVQhJZRN27BYq6pZcZasZ9_Gya3Yed1Lfy-c1OL3hvOdkH7QyoCoVMV5wWjOZEEqRWuGMJFIorYmFUIqeuWz12h38v5WGvNgiJGYchBzDiLmIKYcBI2ii1m0G-seGgU2NsEsXrI8sXojOvdTlLwoaV5Fg7d7A-9-jBAG0eugwBhpwY1B5EW8E8enTujrGe1krEfb1kVHNeFiVSJWUMLLIlLn_6Di10CvVZyrGDcsBe8WgsgMcDd0cgxBrL_eLNk3B-wGpBk2wZlxyjwswVeHfXloyJ-BjACeAeVdCB7a_2o2-0uj9CCnu2OJ2jyq3Gcb4i22Ay-2bvQ2juYjol9wwhJP
CitedBy_id crossref_primary_10_5812_jkums_131043
crossref_primary_10_1042_BSR20210908
crossref_primary_10_2147_MNM_S263813
crossref_primary_10_2174_1381612828666220516090245
crossref_primary_10_1186_s12935_022_02705_9
crossref_primary_10_1016_j_ncrna_2023_03_004
crossref_primary_10_1038_s41598_024_56078_2
crossref_primary_10_5812_jkums_122802
crossref_primary_10_3390_genes11030312
crossref_primary_10_1186_s13148_021_01135_0
crossref_primary_10_18632_aging_203048
crossref_primary_10_1016_j_mcp_2022_101869
crossref_primary_10_3389_fonc_2021_650037
crossref_primary_10_2174_0113816128300061240319034243
crossref_primary_10_3390_cells9081864
crossref_primary_10_1016_j_ncrna_2020_02_004
crossref_primary_10_1186_s12885_022_09659_1
crossref_primary_10_1016_j_csbj_2020_11_004
crossref_primary_10_1016_j_intimp_2021_108168
crossref_primary_10_3748_wjg_v25_i34_5026
crossref_primary_10_1016_j_bbrc_2021_03_132
crossref_primary_10_1016_j_prp_2024_155746
crossref_primary_10_1111_jcmm_70421
crossref_primary_10_18632_aging_103436
crossref_primary_10_2147_CMAR_S269679
crossref_primary_10_32604_biocell_2022_019724
crossref_primary_10_3390_cancers14071820
crossref_primary_10_3390_cells11152448
crossref_primary_10_1155_2023_6457152
crossref_primary_10_3389_bjbs_2023_11103
crossref_primary_10_1016_j_pbiomolbio_2023_04_002
crossref_primary_10_3390_cancers11121994
crossref_primary_10_1007_s12253_020_00800_8
crossref_primary_10_1186_s12935_023_02867_0
crossref_primary_10_1007_s12033_022_00628_4
Cites_doi 10.1080/21691401.2018.1464462
10.1371/journal.pone.0048547
10.1098/rsob.170121
10.1097/PAT.0000000000000125
10.1155/2017/7243968
10.1186/1480-9222-16-11
10.1007/s11010-017-3177-8
10.1155/2016/9085195
10.1038/cddis.2017.60
10.7150/jca.19794
10.1007/s12032-013-0588-6
10.1101/gad.1800909
10.1111/cas.13058
10.1038/srep23892
10.1002/cam4.1696
10.1038/nature11252
10.1186/1471-2407-13-196
10.1016/j.febslet.2008.05.012
10.1007/s13277-014-2321-2
10.1038/cddis.2013.541
10.1177/1947601911431081
10.1186/s13578-015-0050-x
10.1186/s12885-015-1687-x
10.1186/s13148-016-0305-3
10.1158/1541-7786.MCR-11-0342
10.1093/nar/gkx1107
10.18632/oncotarget.23431
10.1016/j.lfs.2017.08.024
10.1038/s41598-017-18407-6
10.18632/oncotarget.3219
10.1186/s12943-016-0530-6
10.3892/ijo.2015.3109
10.1016/j.critrevonc.2008.08.001
10.18632/oncotarget.6446
10.1038/modpathol.2012.160
10.1016/j.jbi.2011.05.002
10.1002/jcb.25606
10.1038/modpathol.2014.33
10.4161/rna.20481
10.1038/nrg3606
10.1186/1476-4598-10-38
10.1002/2211-5463.12060
10.3390/ijms160819886
10.3389/fgene.2016.00054
10.1007/s00432-015-2042-y
10.1371/journal.pone.0133836
10.15419/bmrat.v4i10.372
10.1186/1741-7007-11-59
10.1038/nmeth.1226
10.1016/j.ccell.2015.09.006
10.3390/ncrna4030020
ContentType Journal Article
Copyright The Author(s). 2019
COPYRIGHT 2019 BioMed Central Ltd.
Copyright_xml – notice: The Author(s). 2019
– notice: COPYRIGHT 2019 BioMed Central Ltd.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
7X8
5PM
ADTOC
UNPAY
DOA
DOI 10.1186/s12885-019-6180-5
DatabaseName SpringerOpen Free (Free internet resource, activated by CARLI)
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList


MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2407
EndPage 16
ExternalDocumentID oai_doaj_org_article_9c98837527a349c5b7014a0a0fb4900c
10.1186/s12885-019-6180-5
PMC6836529
A607354863
31694571
10_1186_s12885_019_6180_5
Genre Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: Novo Nordisk Foundation Interdisciplinary Synergy Programme Grant
  grantid: NNF15OC0016584
– fundername: The New National Excellence Program of the Ministry of Human Capacities, Hungary
  grantid: ÚNKP-17-4-I-SE-56; ÚNKP-17-4-III-SE-51
– fundername: Nemzeti Kutatási és Technológiai Hivatal
  grantid: KMR 12-1-2012-0216; NKVP_16-1-2016-0004
  funderid: http://dx.doi.org/10.13039/501100003827
– fundername: Nemzeti Kutatási és Technológiai Hivatal
  grantid: NKVP_16-1-2016-0004
– fundername: The New National Excellence Program of the Ministry of Human Capacities, Hungary
  grantid: ÚNKP-17-4-I-SE-56
– fundername: The New National Excellence Program of the Ministry of Human Capacities, Hungary
  grantid: ÚNKP-17-4-III-SE-51
– fundername: Nemzeti Kutatási és Technológiai Hivatal
  grantid: KMR 12-1-2012-0216
– fundername: ;
  grantid: KMR 12-1-2012-0216; NKVP_16-1-2016-0004
– fundername: ;
  grantid: ÚNKP-17-4-I-SE-56; ÚNKP-17-4-III-SE-51
– fundername: ;
  grantid: NNF15OC0016584
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ISR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
CITATION
-A0
3V.
ACRMQ
ADINQ
ALIPV
C24
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
2VQ
4.4
ADTOC
AHSBF
C1A
IPNFZ
LGEZI
LOTEE
NADUK
NXXTH
RIG
UNPAY
ID FETCH-LOGICAL-c640t-a77799eccd642457d49f98450f4ec05b8eed4644558b1f59c3aae6dfd7407cb73
IEDL.DBID M48
ISSN 1471-2407
IngestDate Tue Oct 14 18:57:18 EDT 2025
Sun Oct 26 04:15:15 EDT 2025
Tue Sep 30 16:41:26 EDT 2025
Fri Sep 05 13:10:59 EDT 2025
Mon Oct 20 22:16:25 EDT 2025
Mon Oct 20 16:33:21 EDT 2025
Thu Oct 16 14:58:28 EDT 2025
Thu May 22 21:05:28 EDT 2025
Thu Jan 02 22:58:56 EST 2025
Wed Oct 01 03:44:57 EDT 2025
Thu Apr 24 23:01:24 EDT 2025
Sat Sep 06 07:18:36 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Immunohistochemistry
Colorectal adenoma
lncRNA
Colorectal cancer
qRT-PCR
UCA1
Human transcriptome Array 2.0
Microarray
hybridization
Long non-coding RNA
In situ hybridization
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
cc-by
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c640t-a77799eccd642457d49f98450f4ec05b8eed4644558b1f59c3aae6dfd7407cb73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-3824-1534
OpenAccessLink https://link.springer.com/10.1186/s12885-019-6180-5
PMID 31694571
PQID 2312810149
PQPubID 23479
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_9c98837527a349c5b7014a0a0fb4900c
unpaywall_primary_10_1186_s12885_019_6180_5
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6836529
proquest_miscellaneous_2312810149
gale_infotracmisc_A607354863
gale_infotracacademiconefile_A607354863
gale_incontextgauss_ISR_A607354863
gale_healthsolutions_A607354863
pubmed_primary_31694571
crossref_primary_10_1186_s12885_019_6180_5
crossref_citationtrail_10_1186_s12885_019_6180_5
springer_journals_10_1186_s12885_019_6180_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-11-06
PublicationDateYYYYMMDD 2019-11-06
PublicationDate_xml – month: 11
  year: 2019
  text: 2019-11-06
  day: 06
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC cancer
PublicationTitleAbbrev BMC Cancer
PublicationTitleAlternate BMC Cancer
PublicationYear 2019
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References T Wang (6180_CR54) 2014; 35
Y Yang (6180_CR10) 2015; 5
MDH Palermo (6180_CR29) 2014; 25
M Xue (6180_CR51) 2016; 142
J Shi (6180_CR59) 2015; 5
Z Bian (6180_CR48) 2016; 6
6180_CR19
MF Gayyed (6180_CR57) 2015; 6
YL Wang (6180_CR60) 2018; 9
J Huang (6180_CR45) 2014; 5
X Yan (6180_CR20) 2015; 28
A Mortazavi (6180_CR28) 2008; 5
A Yamada (6180_CR37) 2018; 8
V Barresi (6180_CR17) 2016; 6
LD Graham (6180_CR32) 2011; 2
AV Patai (6180_CR39) 2015; 10
F Wang (6180_CR43) 2008; 582
Z Zhang (6180_CR35) 2018; 39
Y Han (6180_CR46) 2014; 46
HS Gandomani (6180_CR1) 2017; 4
A Fatica (6180_CR27) 2014; 15
JE Wilusz (6180_CR8) 2009; 23
EA Gibb (6180_CR15) 2011; 10
B Ni (6180_CR44) 2015; 47
T Gutschner (6180_CR7) 2012; 9
AT De Oliveira (6180_CR58) 2009; 29
B Ni (6180_CR47) 2015; 47
L Qiao (6180_CR42) 2018; 441
AE Kornienko (6180_CR6) 2013; 11
O Galamb (6180_CR18) 2012; 7
JF Reid (6180_CR56) 2012; 10
MD Xu (6180_CR24) 2014; 27
CM Anderson (6180_CR16) 2016; 117
T Liu (6180_CR31) 2016; 9
JJ Wang (6180_CR33) 2017; 39
P Qi (6180_CR3) 2013; 26
E Saus (6180_CR26) 2016; 7
PY Cheah (6180_CR2) 2009; 69
J Wang (6180_CR14) 2015; 16
Wanfu Xu (6180_CR55) 2017; 8
Luka Bolha (6180_CR4) 2017; 2017
ZB Nagy (6180_CR21) 2017; 9
K Tao (6180_CR50) 2015; 8
H Dweep (6180_CR22) 2011; 44
L Qiao (6180_CR41) 2017; 188
Ting Shi (6180_CR5) 2016; 2016
SS Fang (6180_CR13) 2018; 46
YT Yang (6180_CR49) 2016; 107
J Cao (6180_CR11) 2014; 16
Y Yang (6180_CR12) 2017; 8
X Xie (6180_CR25) 2016; 7
M. Joaquina Delás (6180_CR38) 2017; 7
N Bartonicek (6180_CR9) 2016; 15
Manish Tripathi (6180_CR52) 2018; 4
6180_CR36
A Kalmar (6180_CR23) 2015; 15
Meng Li (6180_CR34) 2018; 7
B Alaiyan (6180_CR30) 2013; 13
F Wang (6180_CR53) 2015; 6
X Ge (6180_CR40) 2013; 30
References_xml – ident: 6180_CR36
  doi: 10.1080/21691401.2018.1464462
– volume: 7
  start-page: e48547
  issue: 11
  year: 2012
  ident: 6180_CR18
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0048547
– volume: 7
  start-page: 170121
  issue: 7
  year: 2017
  ident: 6180_CR38
  publication-title: Open Biology
  doi: 10.1098/rsob.170121
– volume: 46
  start-page: 396
  issue: 5
  year: 2014
  ident: 6180_CR46
  publication-title: Pathology
  doi: 10.1097/PAT.0000000000000125
– volume: 2017
  start-page: 1
  year: 2017
  ident: 6180_CR4
  publication-title: Disease Markers
  doi: 10.1155/2017/7243968
– volume: 16
  start-page: 11
  year: 2014
  ident: 6180_CR11
  publication-title: Biol Procedures Online
  doi: 10.1186/1480-9222-16-11
– volume: 441
  start-page: 99
  issue: 1-2
  year: 2018
  ident: 6180_CR42
  publication-title: Mol Cell Biochem
  doi: 10.1007/s11010-017-3177-8
– volume: 2016
  start-page: 1
  year: 2016
  ident: 6180_CR5
  publication-title: Disease Markers
  doi: 10.1155/2016/9085195
– volume: 8
  start-page: e2761
  issue: 5
  year: 2017
  ident: 6180_CR55
  publication-title: Cell Death & Disease
  doi: 10.1038/cddis.2017.60
– volume: 5
  start-page: 2258
  issue: 7
  year: 2015
  ident: 6180_CR59
  publication-title: Am J Cancer Res
– volume: 8
  start-page: 3212
  issue: 16
  year: 2017
  ident: 6180_CR12
  publication-title: J Cancer
  doi: 10.7150/jca.19794
– volume: 30
  start-page: 588
  issue: 2
  year: 2013
  ident: 6180_CR40
  publication-title: Med Oncol
  doi: 10.1007/s12032-013-0588-6
– volume: 23
  start-page: 1494
  issue: 13
  year: 2009
  ident: 6180_CR8
  publication-title: Genes Dev
  doi: 10.1101/gad.1800909
– volume: 107
  start-page: 1581
  issue: 11
  year: 2016
  ident: 6180_CR49
  publication-title: Cancer Sci
  doi: 10.1111/cas.13058
– volume: 6
  start-page: 23892
  year: 2016
  ident: 6180_CR48
  publication-title: Sci Rep
  doi: 10.1038/srep23892
– volume: 7
  start-page: 4650
  issue: 9
  year: 2018
  ident: 6180_CR34
  publication-title: Cancer Medicine
  doi: 10.1002/cam4.1696
– ident: 6180_CR19
  doi: 10.1038/nature11252
– volume: 13
  start-page: 196
  year: 2013
  ident: 6180_CR30
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-13-196
– volume: 582
  start-page: 1919
  issue: 13
  year: 2008
  ident: 6180_CR43
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2008.05.012
– volume: 35
  start-page: 10075
  issue: 10
  year: 2014
  ident: 6180_CR54
  publication-title: Tumour Biol
  doi: 10.1007/s13277-014-2321-2
– volume: 6
  start-page: 618
  issue: 6
  year: 2015
  ident: 6180_CR57
  publication-title: J Gastrointest Oncol
– volume: 5
  start-page: e1008
  year: 2014
  ident: 6180_CR45
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2013.541
– volume: 2
  start-page: 829
  issue: 8
  year: 2011
  ident: 6180_CR32
  publication-title: Genes Cancer
  doi: 10.1177/1947601911431081
– volume: 5
  start-page: 59
  year: 2015
  ident: 6180_CR10
  publication-title: Cell Bioscience
  doi: 10.1186/s13578-015-0050-x
– volume: 15
  start-page: 736
  year: 2015
  ident: 6180_CR23
  publication-title: BMC Cancer
  doi: 10.1186/s12885-015-1687-x
– volume: 25
  start-page: S20
  issue: Suppl
  year: 2014
  ident: 6180_CR29
  publication-title: J Biomol Tech
– volume: 9
  start-page: 22
  year: 2017
  ident: 6180_CR21
  publication-title: Clin Epigenetics
  doi: 10.1186/s13148-016-0305-3
– volume: 10
  start-page: 504
  issue: 4
  year: 2012
  ident: 6180_CR56
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-11-0342
– volume: 46
  start-page: D308
  issue: D1
  year: 2018
  ident: 6180_CR13
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkx1107
– volume: 9
  start-page: 21687
  issue: 31
  year: 2018
  ident: 6180_CR60
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.23431
– volume: 188
  start-page: 37
  year: 2017
  ident: 6180_CR41
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2017.08.024
– volume: 8
  start-page: 575
  issue: 1
  year: 2018
  ident: 6180_CR37
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-18407-6
– volume: 6
  start-page: 7899
  issue: 10
  year: 2015
  ident: 6180_CR53
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3219
– volume: 15
  start-page: 43
  issue: 1
  year: 2016
  ident: 6180_CR9
  publication-title: Mol Cancer
  doi: 10.1186/s12943-016-0530-6
– volume: 47
  start-page: 1329
  issue: 4
  year: 2015
  ident: 6180_CR44
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2015.3109
– volume: 69
  start-page: 45
  issue: 1
  year: 2009
  ident: 6180_CR2
  publication-title: Crit Rev Oncol Hematol
  doi: 10.1016/j.critrevonc.2008.08.001
– volume: 7
  start-page: 5226
  issue: 5
  year: 2016
  ident: 6180_CR25
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.6446
– volume: 26
  start-page: 155
  issue: 2
  year: 2013
  ident: 6180_CR3
  publication-title: Modern Pathol
  doi: 10.1038/modpathol.2012.160
– volume: 44
  start-page: 839
  issue: 5
  year: 2011
  ident: 6180_CR22
  publication-title: J Biomed Inform
  doi: 10.1016/j.jbi.2011.05.002
– volume: 117
  start-page: 2201
  issue: 10
  year: 2016
  ident: 6180_CR16
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.25606
– volume: 27
  start-page: 1310
  issue: 10
  year: 2014
  ident: 6180_CR24
  publication-title: Modern Pathol
  doi: 10.1038/modpathol.2014.33
– volume: 8
  start-page: 21854
  issue: 11
  year: 2015
  ident: 6180_CR50
  publication-title: Int J Clin Exp Med
– volume: 9
  start-page: 703
  issue: 6
  year: 2012
  ident: 6180_CR7
  publication-title: RNA Biol
  doi: 10.4161/rna.20481
– volume: 15
  start-page: 7
  issue: 1
  year: 2014
  ident: 6180_CR27
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg3606
– volume: 39
  start-page: 2101
  issue: 5
  year: 2018
  ident: 6180_CR35
  publication-title: Oncol Rep
– volume: 10
  start-page: 38
  year: 2011
  ident: 6180_CR15
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-10-38
– volume: 6
  start-page: 794
  issue: 8
  year: 2016
  ident: 6180_CR17
  publication-title: FEBS Open Bio
  doi: 10.1002/2211-5463.12060
– volume: 16
  start-page: 19886
  issue: 8
  year: 2015
  ident: 6180_CR14
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms160819886
– volume: 7
  start-page: 54
  year: 2016
  ident: 6180_CR26
  publication-title: Front Genet
  doi: 10.3389/fgene.2016.00054
– volume: 142
  start-page: 1407
  issue: 7
  year: 2016
  ident: 6180_CR51
  publication-title: J Cancer Res Clin Oncol
  doi: 10.1007/s00432-015-2042-y
– volume: 10
  start-page: e0133836
  issue: 8
  year: 2015
  ident: 6180_CR39
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0133836
– volume: 4
  start-page: 1656
  issue: 10
  year: 2017
  ident: 6180_CR1
  publication-title: Biomed Res Ther
  doi: 10.15419/bmrat.v4i10.372
– volume: 39
  start-page: 756
  issue: 6
  year: 2017
  ident: 6180_CR33
  publication-title: Zhongguo Yi Xue Ke Xue Yuan Xue Bao
– volume: 29
  start-page: 4807
  issue: 11
  year: 2009
  ident: 6180_CR58
  publication-title: Anticancer Res
– volume: 11
  start-page: 59
  year: 2013
  ident: 6180_CR6
  publication-title: BMC Biol
  doi: 10.1186/1741-7007-11-59
– volume: 5
  start-page: 621
  issue: 7
  year: 2008
  ident: 6180_CR28
  publication-title: Nat Methods
  doi: 10.1038/nmeth.1226
– volume: 9
  start-page: 1437
  year: 2016
  ident: 6180_CR31
  publication-title: OncoTargets Ther
– volume: 28
  start-page: 529
  issue: 4
  year: 2015
  ident: 6180_CR20
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2015.09.006
– volume: 47
  start-page: 1329
  issue: 4
  year: 2015
  ident: 6180_CR47
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2015.3109
– volume: 4
  start-page: 20
  issue: 3
  year: 2018
  ident: 6180_CR52
  publication-title: Non-Coding RNA
  doi: 10.3390/ncrna4030020
SSID ssj0017808
Score 2.4420223
Snippet Background Long non-coding RNAs (lncRNAs) play a fundamental role in colorectal cancer (CRC) development, however, lncRNA expression profiles in CRC and its...
Long non-coding RNAs (lncRNAs) play a fundamental role in colorectal cancer (CRC) development, however, lncRNA expression profiles in CRC and its precancerous...
Background Long non-coding RNAs (lncRNAs) play a fundamental role in colorectal cancer (CRC) development, however, lncRNA expression profiles in CRC and its...
Abstract Background Long non-coding RNAs (lncRNAs) play a fundamental role in colorectal cancer (CRC) development, however, lncRNA expression profiles in CRC...
SourceID doaj
unpaywall
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1059
SubjectTerms Adenoma
Adenoma - genetics
Adenoma - pathology
Adult
Advertising executives
Aged
Algorithms
Analysis
Biomedical and Life Sciences
Biomedicine
Biotechnology industries
Cancer genetics
Cancer Research
Carcinogenesis
Carcinoma
Carcinoma - genetics
Carcinoma - pathology
Colorectal adenoma
Colorectal cancer
Colorectal Neoplasms - genetics
Colorectal Neoplasms - pathology
Development and progression
Gastrointestinal diseases
Gene Expression Profiling - methods
Gene Expression Regulation, Neoplastic
Gene Ontology
Gene Regulatory Networks
Genetics
Genomes
Genomics
genomics and epigenetics
Health Promotion and Disease Prevention
Human transcriptome Array 2.0
Humans
Immunohistochemistry
lncRNA
Long non-coding RNA
Medicine/Public Health
Messenger RNA
Microarray
MicroRNA
Middle Aged
Models, Genetic
Oncology
Research Article
RNA
RNA, Long Noncoding - genetics
Surgical Oncology
Tumors
Young Adult
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQDzwOiDeBAgEhIVFFdRI_jwuiFKT2UKjUm-U4TrvS1qmaXRX-PTOJN9qA1F64rdbfWvLMeB474xlC3tuqqJ0smozWVmessXmmPJWZ9Cyvau-t5vjA-eBQ7B-z7yf8ZGPUF9aEDe2BB8LtaqcVBFG8kLZk2vFKglNvqaVNxTSlDrUvVXodTMX8gVRUxRxmrsRuB1pYYZGahlBJ0YxPrFDfrP9flbxhk_6ulxyTpvfInVW4sL-v7GKxYZf2HpD70aFMZ8NBHpJbPjwitw9iyvwxOf_qQ3vus6t57VP_K9a9hnQY1g3bp_OQYutqVH2wkUMxuEyb1mFJ_GkK0EVwR4ezDoHgLqa2xh1t5nAMEX5Kl2jw-tqvJ-R478vPz_tZnLGQOcHoMrNSSq2Bj7XAHKismW60Ypw2zDvKKwU2lIHPxLmq8oZrV1rrRd3UEiJBV8nyKdkKbfDPSaoBQRlE6rrkzNWyUq6QrlCWe140skgIXdPcuNiAHOdgLEwfiChhBjYZYJNBNhmekI_jTy6G7hvXgT8hI0cgNs7uvwBxMlGczE3ilJA3KAZmeIU6Xn8zE6ALIboTZULe9QhsnhGwOufUrrrOfPtxNAF9iKCmhTM6Gx87AKWw39YEuT1Bwu12k-W3a3k0uIQlccG3q86AY15gdzamE_JskM_x6GUuNDAzT4icSO6ENtOVMD_rm4sLVQpewJ47axk3Uat115F-Z7wGNzPqxf9g1Etyt8D7jP_wi22ytbxc-VfgHy6r170q-APO3F6e
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEF-0gh8P4rfRqlEEwRLcS_bz8RRrFdqH6kHfls1mcx5cN-VyR_W_dybZC41Kxbfj9peB7HxnZmcJeW3LvHIyrzNaWZ2x2k4y5anMpGeTsvLeao4HnA-PxMGMfTnhJ_Ecd7vtdt-WJDtL3am1Eu9asKQKG800pDuKZvwqucZxmhcI8SyfDqUDqaiK5cu_PjZyQN2c_j-t8QV39Hur5FAvvUVubMKZ_Xlul8sLLmn_DrkdY8l02jP_Lrniwz1y_TBWy--T008-NKc-O19UPvU_YstrSPt7uoF8uggpTq1GqweEHErAKq0bh93w8xSgy-COj6YtAiFSTG2FFG3m8AYi_JWu0dd1bV8PyGz_47cPB1m8XiFzgtF1ZqWUWgMLK4HlT1kxXWvFOK2Zd5SXCtwng3CJc1VOaq5dYa0XVV1JSAJdKYuHZCc0wT8mqQYEZZCk64IzV8lSuVy6XFnueV7LPCF0u-fGxdnjeAXG0nQ5iBKmZ5MBNhlkk-EJeTs8ctYP3rgM_B4ZOQBxZnb3R7Oam6iCRjutIB3nubQF046XEtJDSy2tS6YpdQl5gWJg-gOog-abqQAzCImdKBLyqkPg3IyAjTlzu2lb8_nr8Qj0JoLqBt7R2XjOAXYKR22NkLsjJCi2Gy2_3MqjwSXshgu-2bQGYvIcB7MxnZBHvXwOr15MhAZmThIiR5I72pvxSlh87-aKC1UIngPNva2Mm2jQ2su2fm9Qg38z6sl_0X5KbuaouPgVX-ySnfVq459BDLgun3c6_wv2tFPT
  priority: 102
  providerName: Springer Nature
– databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3ra9RAEF_0Cj4--H5Eq0YRBEuueezz4ynWKvSQaqF-WjabzXk0zR2XO6r-9c4kuXCpUhH8FrK_LNnZmdkZ5rGEvDRpnFkR50GYGRXQ3ESBdKEIhKNRmjlnFMMC54Mx3z-iH4_ZcXsdENbCpKc4pXWL4Wb5eVHrbHiwJ7vzLG9EXfLdCrSrxOQzBS6QDAM2hNHLZIszMMwHZOto_Gn0ta4vEhHGEUQb1_zjt72TqW7g_7ua3jinzudQdoHU6-TqqpybH2emKDbOqr2bpFivsklRORmulunQ_jzXAPI_keEWudHatP6oYcLb5JIr75ArB23U_i45fe9KmD44m2bOd9_b1NvSb-4Lh9X409LH7tmofWGi5p_8fGYxK3_iA7Qo7eF4VCEQLFbfZDijCSzehIRP_hLP3Dr97B452nv35e1-0F7zEFhOw2VghBBKAStlHMOwIqMqV5KyMKfOhiyVcIxTMNsYk2mUM2UTYxzP8kzAhtpUJPfJoJyV7iHxFSBC6lKwYRi1mUiljYWNpWGOxbmIPRKut1jbtgc6XsVR6NoXklw3pNRASo2k1Mwjr7tP5k0DkIvAb5BvOiD27q5fzBYT3aoCraySMhEsFiahyrJUgJtqQhPmKVVhaD3yDLlON4WwnQbSIw7qGBxMnnjkRY3A_h0lJghNzKqq9IfPhz3QqxaUz5BlTFtvAZTCll895HYPCQrG9oafr9lf4xBm5ZVutqo0-AYxNoijyiMPGnHolp5EXMFmRh4RPUHp0aY_Uk6_1f3NuUw4i2HOnbVI6VaxVheRfqeTur9v1KN_Qj8m12IULowm8G0yWC5W7gnYosv0aatjfgHxGIIZ
  priority: 102
  providerName: Unpaywall
Title Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition
URI https://link.springer.com/article/10.1186/s12885-019-6180-5
https://www.ncbi.nlm.nih.gov/pubmed/31694571
https://www.proquest.com/docview/2312810149
https://pubmed.ncbi.nlm.nih.gov/PMC6836529
https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-019-6180-5.pdf
https://doaj.org/article/9c98837527a349c5b7014a0a0fb4900c
UnpaywallVersion publishedVersion
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMedCentral
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: RBZ
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: KQ8
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: DOA
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: Academic Search Ultimate - eBooks
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: ABDBF
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: DIK
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: M~E
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: RPM
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: 7X7
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 20250930
  omitProxy: true
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: M48
  dateStart: 20010801
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
– providerCode: PRVAVX
  databaseName: HAS SpringerNature Open Access 2022
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: AAJSJ
  dateStart: 20011201
  isFulltext: true
  titleUrlDefault: https://www.springernature.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: Springer Nature OA Free Journals
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: C6C
  dateStart: 20010112
  isFulltext: true
  titleUrlDefault: http://www.springeropen.com/
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: U2A
  dateStart: 20011201
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR3ZbtNAcNU2EscD4iZQgkFISFQGx97zAaEkailIiapApJSX1Xq9DpFSu-RQ279nxnFMDVX7YjneyUqeezyzM4S8NXGYWBGmfpAY5dPUtH3pAuELR9tx4pxRDA849wf8cES_jdl4i2zGW5UIXFwZ2uE8qdF89uH898VnEPhPhcBL_nEBOlZiCZqCQEgGPtsmDTBUCic59OnfpIKQxYC6NuhjTCqIMsl55RY1M1V08_9fZ18yWv8WVFZZ1bvk9io7NRdnZja7ZLgO7pN7pcfpddYs8oBsuewhudUvc-qPyMkXl-Unzj-bJs5z52VhbOatp3nD9t4087C3NepG2Mgin8y9NLdYMz_xAHSW2eGgs0BA8Cc9k-COxrc4pwjvvCVaxKI47DEZHez_6B365RAG33IaLH0jhFAKCJ1wTJKKhKpUScqClDobsFiCkaXgVDEm43bKlI2McTxJEwEYtrGInpCdLM_cM-IpgAgohPIqYtQmIpY2FDaUhjkWpiJskmCDc23LDuU4KGOmi0hFcr0mkwYyaSSTZk3yvvrL6bo9x3XAXSRkBYidtYsH-XyiS0HVyioJQTsLhYmosiwWEESawARpTFUQ2CZ5hWyg18dUK_2gOxyUJYR_PGqSNwUEdtfIsHxnYlaLhf76fVgDelcCpTm8ozXlaQjAFDbkqkHu1iBB_G1t-fWGHzUuYc1c5vLVQoPnHmL7Nqqa5OmaP6tXj9pcATHbTSJqnFvDTX0lm_4quo9zGXEWwp57Gx7XG6m9DvV7lRjcTKjnN-L4BbkTorDi932-S3aW85V7Cd7hMm6RbTEWLdLo7g-OhvCrx3ut4ktLq9AGcB12f8J1FMKTxmhw1Dn-Aw8cZRw
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdgkxg8IL4JDBYQEhJThJvYsf1YEKMrax_2Ie3NchynVOqSqWk1-O-5S9xoATTEW1X_clJ837nzmZB3JotzK-IiorlRESvMIJKOikg4Nshy54zieMB5Mk1HZ2x8zs_9Oe560-2-KUk2lrpRa5l-rMGSSmw0U5DuSBrx22Qbe6xAG7eHw_HJuCseCEmlL2D-9cGeC2om9f9pj685pN-bJbuK6T2ysy4vzc8rs1hcc0oHD8h9H02Gw5b9D8ktVz4idya-Xv6YXHx1ZXXhoqt57kL3wze9lmF7UzeQD-dliHOr0e4BIYsysAyLymI__CwE6KK0x9NhjUCIFUOTI0UTWbyDCH-FK_R2TePXE3J28OX08yjyFyxENmV0FRkhhFLAxDzFAqjImSqUZJwWzFnKMwkOlEHAxLnMBgVXNjHGpXmRC0gDbSaSp2SrrEr3nIQKEJRBmq4SzmwuMmljYWNpuONxIeKA0M2ea-unj-MlGAvdZCEy1S2bNLBJI5s0D8iH7pHLdvTGTeBPyMgOiFOzmz-q5Ux7JdTKKgkJOY-FSZiyPBOQIBpqaJExRakNyB6KgW6PoHa6r4cpGEJI7dIkIG8bBE7OKLE1Z2bWda0PT457oPceVFTwjtb4kw6wUzhsq4fc7SFBtW1v-c1GHjUuYT9c6ap1rSEqj3E0G1MBedbKZ_fqySBVwMxBQERPcnt7018p59-byeKpTFIeA839jYxrb9Lqm7Z-v1ODfzPqxX_R3iM7o9PJkT46nH57Se7GqMT4TT_dJVur5dq9gohwlb32FuAXlCNYCA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdgSAMeEF-DwGABISExRXMTfz6WQtmAVWgwaW-W4zilUpdUTavBf89dkkYLoCHeqvqXk-L78uXOd4S8smmcORnnEc2sjlhuB5HyVEbSs0GaeW81xwvOxxNxeMo-nvGzds5ptal236QkmzsN2KWpWB0ssrxRcSUOKrCqCovONIQ-ikb8OrnBwLnhCIORGHVpBKmoalOZf32s54zqnv1_WuZLrun3sskud3qb3FwXC_vzws7nl9zT-C65054rw2EjCPfINV_cJ9vHbeb8ATn_4Ivy3EcXs8yH_kdb_lqEzcxuIB_OihA7WKMFBEIOpWEZ5qXDyvhpCNB54U4mwwqBcGoMbYYUbeRwGhH-Clfo9-oSsIfkdPz-2-gwakctRE4wuoqslFJrYGcmMBUqM6ZzrRinOfOO8lSBK2VwdOJcpYOca5dY60WWZxICQpfKZIdsFWXhH5NQA4IyCNh1wpnLZKpcLF2sLPc8zmUcELrZc-PaPuQ4DmNu6nhECdOwyQCbDLLJ8IC86R5ZNE04rgK_RUZ2QOyfXf9RLqemVUejnVYQmvNY2oRpx1MJoaKlluYp05S6gOyhGJjmMmpnBcxQgEmEIE8kAXlZI7CHRoFFOlO7ripz9PWkB3rdgvIS3tHZ9s4D7BS23eohd3tIUHLXW36xkUeDS1gZV_hyXRk4n8fYpI3pgDxq5LN79WQgNDBzEBDZk9ze3vRXitn3use4UIngMdDc38i4aY1bddXW73dq8G9GPfkv2ntk-8u7sfl8NPn0lNyKUYfx477YJVur5do_g6PhKn1eq_8v0xVa5Q
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3ra9RAEF_0Cj4--H5Eq0YRBEuueezz4ynWKvSQaqF-WjabzXk0zR2XO6r-9c4kuXCpUhH8FrK_LNnZmdkZ5rGEvDRpnFkR50GYGRXQ3ESBdKEIhKNRmjlnFMMC54Mx3z-iH4_ZcXsdENbCpKc4pXWL4Wb5eVHrbHiwJ7vzLG9EXfLdCrSrxOQzBS6QDAM2hNHLZIszMMwHZOto_Gn0ta4vEhHGEUQb1_zjt72TqW7g_7ua3jinzudQdoHU6-TqqpybH2emKDbOqr2bpFivsklRORmulunQ_jzXAPI_keEWudHatP6oYcLb5JIr75ArB23U_i45fe9KmD44m2bOd9_b1NvSb-4Lh9X409LH7tmofWGi5p_8fGYxK3_iA7Qo7eF4VCEQLFbfZDijCSzehIRP_hLP3Dr97B452nv35e1-0F7zEFhOw2VghBBKAStlHMOwIqMqV5KyMKfOhiyVcIxTMNsYk2mUM2UTYxzP8kzAhtpUJPfJoJyV7iHxFSBC6lKwYRi1mUiljYWNpWGOxbmIPRKut1jbtgc6XsVR6NoXklw3pNRASo2k1Mwjr7tP5k0DkIvAb5BvOiD27q5fzBYT3aoCraySMhEsFiahyrJUgJtqQhPmKVVhaD3yDLlON4WwnQbSIw7qGBxMnnjkRY3A_h0lJghNzKqq9IfPhz3QqxaUz5BlTFtvAZTCll895HYPCQrG9oafr9lf4xBm5ZVutqo0-AYxNoijyiMPGnHolp5EXMFmRh4RPUHp0aY_Uk6_1f3NuUw4i2HOnbVI6VaxVheRfqeTur9v1KN_Qj8m12IULowm8G0yWC5W7gnYosv0aatjfgHxGIIZ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genome-wide+expression+profiling+in+colorectal+cancer+focusing+on+lncRNAs+in+the+adenoma-carcinoma+transition&rft.jtitle=BMC+cancer&rft.au=Igaz%2C+Peter&rft.au=Wichmann%2C+Barnab%C3%A1s&rft.au=Tulassay%2C+Zsolt&rft.au=Nagy%2C+Zs%C3%B3fia+Brigitta&rft.date=2019-11-06&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2407&rft.eissn=1471-2407&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1186%2Fs12885-019-6180-5&rft.externalDBID=n%2Fa&rft.externalDocID=A607354863
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon